A new national study will investigate the long-term effects of lung inflammation and scarring from COVID-19. The study, launched with £2 million of funding from UK Research and Innovation (UKRI), aims to develop treatment strategies and prevent disability. Many people recovering from COVID-19 suffer from long-term symptoms of lung damage, including breathlessness, coughing, fatigue and […]
Oxford Brookes University’s successful work in commercialising its intellectual property (IP), predominantly through IP licensing but also through spinouts, has been ranked in the top 10% of English universities in the first Knowledge Exchange Framework results published today [Wednesday 31 March] by Research England. Oxford Brookes was placed in the top 40% for its research […]
Professor Gary Ford, Chief Executive of the Oxford Academic Health Science Network and consultant stroke physician at OUH, is the new Chair of the AHSN Network, the national body bringing together England’s 15 AHSNs. Gary said: “I am delighted to be taking on this role at an important time for AHSNs and the wider NHS. […]
A project set to be the world’s largest study into the effects of exercise on the successful treatment of children with cancer has begun, with scientists from Oxford Brookes University taking a leading role. The five and a half year project, named FORTEe, has received €6.2 million (£5.4 million) funding from the EU Horizon programme and involves 16 […]
Medical research into eye genetics at Oxford Brookes University has received a funding pledge of £2 million from Baillie Gifford, an international investment business. The gift supports the work of Professor Nicola Ragge who has spearheaded a national eye genetics service, leading world-leading research into eye development problems in children. Specialising in cases where babies are […]
An international research team led by the Townsend Group at the Medical Research Council Human Immunology Unit ((MRC HIU) with other Oxford University scientists has developed a portable test for antibodies that fight the novel coronavirus that causes COVID-19, published today in Nature Communications. The test, which spots the presence of virus-fighting antibodies rather than a coronavirus infection, can be […]
The first NHS patient has received treatment on the cutting-edge ViewRay MRIdian technology, thanks to a new partnership between the University of Oxford, Oxford University Hospitals (OUH) NHS Foundation Trust and GenesisCare. © Genesis Care The partners, with the support of the John Black Charitable Foundation, have collaborated to establish a ten-year programme of […]
A physiotherapist who works with patients in the Adult Intensive Care Unit at the John Radcliffe Hospital has become the first physio working clinically at Oxford University Hospitals to receive funding from the National Institute for Health Research (NIHR) to study for a PhD. Owen Gustafson, OUH’s lead physiotherapist for the AICU, has been awarded […]
Professor Gary Ford, Chief Executive of the Oxford AHSN, is joining the Board of the National Institute for Health and Care Excellence. Gary is one of six new non-executive directors. They take up their new roles from 1 April 2021. Gary said: “I am delighted to join the NICE Board and bring my experience in clinical […]
The final analyses for this trial are described in Novavax UK and SA Final Data Announcement March 11 2021 FINAL[87] . Part of the Study took place at the Warneford site in Oxford houses both the Oxford Health NHS FT and the University of Oxford’s Department of Psychiatry